Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.082 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.075 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |